Immunic Inc. (IMUX) Misses Q2 EPS by 1c

Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.54), $0.01 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c
• Aspire Biopharma to acquire automotive supplier for $30 million